Abemaciclib and Letrozole in Metastatic Male Breast Cancer
ABSTRACT Background Male breast cancer is a very rare disease and only accounts for around 1% of all breast cancers. The treatment strategies are based on those used for breast cancer in women. So far, there is a lack of randomized data to support specific treatment modalities in men. To our knowled...
Saved in:
| Main Authors: | Leon Schönfeld, Christian Möhring, Rouven Strobel, Hanns Leonhard Kaatsch, Stephan Waldeck, Ulrike Wagner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Cancer Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.70054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
by: Sara M. Tolaney, et al.
Published: (2025-03-01) -
Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities
by: Mashael Algethami, et al.
Published: (2025-08-01) -
Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon
by: Anwar Al Nouri, et al.
Published: (2025-06-01) -
Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy
by: Xianghua Quan, et al.
Published: (2025-06-01) -
Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study
by: Judy King, et al.
Published: (2025-07-01)